PlainRecalls
FDA Drug Moderate Class II Terminated

Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

Reported: March 20, 2024 Initiated: February 22, 2024 #D-0385-2024

Product Description

Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

Reason for Recall

Failed Stability Specification: Water determination was found not complying with specification.

Details

Recalling Firm
Eugia US LLC
Units Affected
1160 VIALS
Distribution
Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.. Recalled by Eugia US LLC. Units affected: 1160 VIALS.
Why was this product recalled?
Failed Stability Specification: Water determination was found not complying with specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2024. Severity: Moderate. Recall number: D-0385-2024.